Brief: Oncolys Biopharma says patent assessment in Japan for OBP-1101
27/06/2016 07:27
June 27 (Reuters) - Oncolys Biopharma Inc 4588.T :
* Says patent assessment in Japan for OBP-1101, which has
been developed as a vitro test drug of cancer
Source text in Japanese: https://goo.gl/IykY3E
Further company coverage: 4588.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724;
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))